Downtown L.A. Law Group is currently accepting clients who are experiencing problems with their Zimmer NexGen knee replacements. Currently, lawsuits are being filed against the manufacturer of the popular Zimmer NexGen knee implants, which has been linked to unnaturally high rates of failure and loosening for its users. The company is under scrutiny for several of their models, including:
Manufactured by Zimmer Inc., these implants have been used by over 500,000 users. The popular defective medical device is advertised to last for roughly fifteen years before it would need to be replaced. The company further claims that their knee replacements provide industry leading range of motion and usability.
Shortly afterwards however, users began experiencing complications and adverse reactions related to their knee implants. These complications include:
More serious complications can also result due to the materials used in the devices. These materials have been associated with infections, bone disintegration (osteolysis), blood clots and cancer
The attorneys at Downtown L.A. Law Group are alleging product liability, negligence and failure to warn claims against the manufacturers of the NexGen CR-Knee implant, including Zimmer, Inc., and Zimmer Holdings, Inc. Specifically, the NexGen implants fails to use cement adhesives, common in most other knee implants, but absent in many of their models.
The Zimmer knee replacement devices first came under by famous orthopedic surgeons Dr. Richard and Dr. Craig Della Valle, who concluded that 36% of implants showed loosening after only 2 years, and that over 9% of the implants necessitated revision due to loosening or because the patients were experiencing discomfort. The study, published in the American Academy of Orthopedic Surgeons, also indicated that the complications were not due to “surgeon, approach, or patient type”… and that it “should not be used by any patient.”
To date, over 700 lawsuit claims have been filed against Zimmer for their defective knee replacement devices. The claims have been directed to U.S. District Court of Northern Illinois under the MDL (multidistrict litigation) case number 2272.
Knee replacement defects are based on proving one of three district product liability based causes of action.
1. Defect in the original design of the product: A design defect can be proven in the court of law by showing the presence of designs and models at the time of manufacturing that possessed a substantially reduced risk of injury to the consumer. Liability is established if the manufacturers failed to use the less dangerous design model as a basis for the manufacturing of the device.
2. Defect in the manufacturing process: A manufacturing defect can be proven by showing that the finally produce and distributed device is markedly different and as a result poses a substantially greater risk than the design approved by the FDA.
3. Failure to warn defect: In certain instances manufacturers fail to warn doctor surgeons and consumers of the medical device of the known risks associated with their use.
Based on these complications and adverse reports, the U.S. Food and Drug Administration (FDA) initiated three product recalls of certain Zimmer knee implants. In September of 2010 the FDA recalled the NexGen Complete Knee Solution MIS Tibial Components, NexGen TM Tibial Trays, and MIS Modular Tibial Plates and Keels. Later that same year, the NexGen LPS-Gender Femoral Component was also recalled. Again, in January 2012, the FDA issued a class II recall of the Natural-Knee II Durasul All-Poly Patella.
In spite of these recalls, Zimmer continues to market, distribute and push it’s cement-less NexGen CR-Flex knee implants.
Our team of attorneys are currently answering questions for individuals suffering from complications related to their Zimmer knee implants. The pressure free, no obligation call is free, and we would be honored to help individuals in need of help. (855)385-2529